
Chronic Wound Care Market Report 2026
Global Outlook – By Product (Advanced Wound Dressing, Surgical Wound Care, Suture And Staples, Tissue Adhesive And Sealants, Anti-infective Dressing, Traditional Wound Care, Wound Therapy Devices), By Application (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Other Applications), By End-User (Hospitals, Clinics, Homecare Settings, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035
Chronic Wound Care Market Overview
• Chronic Wound Care market size has reached to $16.42 billion in 2025 • Expected to grow to $22.49 billion in 2030 at a compound annual growth rate (CAGR) of 6.3% • Growth Driver: Surging Number Of Sports Injuries Driving The Chronic Wound Care Market • Market Trend: Increasing Focus On Innovative Systems In The Chronic Wound Care Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Chronic Wound Care Market?
Chronic wound care refers to the specialized medical treatment and management of wounds that fail to progress through the normal stages of healing within an expected timeframe, often lasting for an extended duration. It is utilized to address a variety of persistent wounds, aiming to promote healing and prevent complications. The main types of chronic wound care products include advanced wound dressing, surgical wound care, sutures and staples, tissue adhesive and sealants, anti-infective dressing, traditional wound care, and wound therapy devices. Advanced wound dressings are innovative materials applied directly to wounds to promote healing and prevent infections, such as hydrocolloids, hydrogels, foams, and films. These are used for several applications, such as diabetic foot ulcers, pressure ulcers, venous leg ulcers, and others, by various end-users, including hospitals, clinics, homecare settings, and others.
What Is The Chronic Wound Care Market Size and Share 2026?
The chronic wound care market size has grown strongly in recent years. It will grow from $16.42 billion in 2025 to $17.64 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising incidence of chronic wounds, increased prevalence of diabetes-related complications, expansion of hospital wound care programs, growing use of surgical wound management products, improved access to wound care therapies.What Is The Chronic Wound Care Market Growth Forecast?
The chronic wound care market size is expected to see strong growth in the next few years. It will grow to $22.49 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing aging population, rising demand for home-based wound care, growing focus on faster wound healing outcomes, expansion of digital wound assessment tools, increasing adoption of advanced therapy devices. Major trends in the forecast period include increasing adoption of advanced wound dressings, rising use of negative pressure wound therapy devices, growing integration of smart wound monitoring solutions, expansion of bioactive and antimicrobial dressings, enhanced focus on personalized wound care.Global Chronic Wound Care Market Segmentation
1) By Product: Advanced Wound Dressing, Surgical Wound Care, Suture And Staples, Tissue Adhesive And Sealants, Anti-infective Dressing, Traditional Wound Care, Wound Therapy Devices 2) By Application: Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Other Applications 3) By End-User: Hospitals, Clinics, Homecare Settings, Other End-Users Subsegments: 1) By Advanced Wound Dressing: Hydrocolloid Dressings, Foam Dressings, Alginate Dressings, Hydrofiber Dressings, Collagen Dressings, Film Dressings, Silicone Dressings, Composite Dressings 2) By Surgical Wound Care: Post-operative Dressings, Surgical Drapes, Surgical Sponges, Adhesive Bandages, Hemostatic Agents 3) By Suture And Staples: Absorbable Sutures, Non-Absorbable Sutures, Surgical Staples, Suture Kits 4) By Tissue Adhesive And Sealants: Cyanoacrylate Adhesives, Fibrin Sealants, Collagen-Based Adhesives, Synthetic Polymers 5) By Anti-Infective Dressing: Silver-Based Dressings, Honey-Based Dressings, Iodine-Based Dressings, Antibiotic-Impregnated Dressings 6) By Traditional Wound Care: Gauze Dressings, Bandages, Cotton Wool, Adhesive Plasters, Antiseptic Creams And Ointments 7) By Wound Therapy Devices: Negative Pressure Wound Therapy (NPWT) Devices, Electrical Stimulation Devices, Oxygen Therapy Devices, Infrared Therapy Devices, Ultrasound Therapy DevicesWhat Is The Driver Of The Chronic Wound Care Market?
The surging number of sports injuries is expected to drive the chronic wound care market going forward. Sports injuries refer to physical harm or trauma sustained during participation in sports or recreational activities. The number of sports injuries is on the rise due to various reasons, such as increased intensity of training, a lack of proper warm-up, inadequate protective gear, and poor technique. Chronic wound care aids in treating the surging number of sports injuries by promoting faster healing, preventing infections, and minimizing the risk of complications, thereby facilitating a quicker return to physical activity. For instance July 2025, according to the Australian Institute of Health and Welfare a Australia-based government agency, in 2023–24, rugby (covering both league and union) recorded the highest sports injury hospitalisation rate relative to participation, with roughly 1,400 hospitalisations per 100,000 participants. Therefore, the surging number of sports injuries is driving the chronic wound care industry.Key Players In The Global Chronic Wound Care Market
Major companies operating in the chronic wound care market are Cardinal Health Inc., Johnson & Johnson, 3M Company, Medtronic PLC, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc., Essity AB (BSN Medical), Medline Industries Inc., Smith & Nephew PLC, Ethicon Inc., Coloplast AS, B. Braun Holding GmbH & Co. KG, Paul Hartmann AG, ConvaTec Group PLC, Mölnlycke Health Care AB, Integra LifeSciences Holdings Corporation, Acelity L.P. Inc., MTF Biologics, MIMEDX Group Inc., Vericel Corporation, Anika Therapeutics Inc., Oneness Biotech Co. Ltd., Marine Polymer Technologies Inc., Tissue Regenix Group PLC, Alleva Medical Ltd.Global Chronic Wound Care Market Trends and Insights
Major companies operating in the chronic wound care market are increasing their focus on developing advanced solutions, such as negative pressure wound therapy (NPWT) systems, to enable more comfortable and convenient home-based treatment. A negative pressure wound therapy (NPWT) system refers to a medical device that applies controlled suction to a wound, promoting healing by removing excess fluid, reducing edema, and enhancing tissue perfusion. For instance, in April 2024, Smith & Nephew, a UK-based medical equipment manufacturing company, launched the RENASYS EDGE in the US as a patient-centric option for treating chronic wounds. This system features a lightweight, compact design and an intuitive interface for clinicians. Its user-friendly interface provides step-by-step advice on therapeutic applications, and technical support is available with a single click during setup via the system's near-field communication function. Smith+Nephew also provides 24-hour patient support and a clinical helpline. Its technological advancements, such as increased portability and the incorporation of near-field communication, not only improve patient comfort but also address the growing demand for effective home-based care, potentially lowering healthcare costs associated with chronic wound management in the wound care market.What Are Latest Mergers And Acquisitions In The Chronic Wound Care Market?
In May 2023, LifeNet Health, a US-based non-profit organization, acquired Bioventus Inc.'s wound care division for $0.085 billion. This acquisition expands LifeNet Health's portfolio with clinically effective products, such as TheraSkin, TheraGenesis, and SonicOne, thereby addressing a healthcare crisis and enhancing patient care while solidifying its position in the chronic wound care market. Bioventus Inc. is a US-based medical device company that provides chronic wound care treatments.Regional Outlook
North America was the largest region in the chronic wound care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Chronic Wound Care Market?
The chronic wound care market consists of revenues earned by entities by providing services, such as wound assessment, wound debridement, infection control, wound dressing changes, negative pressure wound therapy, and patient education. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic wound care market also includes sales of debridement products, moisture control products, and antimicrobial agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Chronic Wound Care Market Report 2026?
The chronic wound care market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chronic wound care industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Chronic Wound Care Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $17.64 billion |
| Revenue Forecast In 2035 | $22.49 billion |
| Growth Rate | CAGR of 7.4% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Cardinal Health Inc., Johnson & Johnson, 3M Company, Medtronic PLC, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc., Essity AB (BSN Medical), Medline Industries Inc., Smith & Nephew PLC, Ethicon Inc., Coloplast AS, B. Braun Holding GmbH & Co. KG, Paul Hartmann AG, ConvaTec Group PLC, Mölnlycke Health Care AB, Integra LifeSciences Holdings Corporation, Acelity L.P. Inc., MTF Biologics, MIMEDX Group Inc., Vericel Corporation, Anika Therapeutics Inc., Oneness Biotech Co. Ltd., Marine Polymer Technologies Inc., Tissue Regenix Group PLC, Alleva Medical Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
